Journal Watch · Science Advances · 2026

Heterogeneous energy-transfer metallaphotocatalysis unlocks direct and site-selective thioglycosylation of unprotected thiosugars.

This work provides a versatile and sustainable tool for precision bioconjugation, offering immediate potential in drug discovery and chemical biology.

Chen H, Yang X, Song Q et al.Science Advances3 min readPharma relevance 50/100

DOI: 10.1126/sciadv.aed3764PMID: 42715335Study type: research study

TL;DR

This work provides a versatile and sustainable tool for precision bioconjugation, offering immediate potential in drug discovery and chemical biology.

Key findings

  • Notably, this method enables the first heterogeneous photocatalytic glycosylation of an antimicrobial peptide mastoparan, enhancing its antitumor activity.
  • This work provides a versatile and sustainable tool for precision bioconjugation, offering immediate potential in drug discovery and chemical biology.

What they did

By embedding nickel catalytic centers within a photoactive covalent organic framework, we create a system that directly excites transient thiosugar-nickel complexes, thereby bypassing the high activation barriers inherent to conventional redox pathways. This approach enables site-selective and stereocontrolled thioglycosylation under mild, operationally simple conditions, featuring a high turnover frequency (114 per hour) and exceptional catalyst recyclability. The broad scope of the method is demonstrated through the glycosylation of diverse substrates, including amino acids and bioactive peptides, without the need for protecting groups.

Full abstract (original)

Background: The creation of glycoconjugates, particularly well-defined glycopeptides, is crucial for advancing biological research and therapeutic development. However, the direct and selective coupling of unprotected thioglycosides to native biomolecules remains a formidable challenge due to the incompatibility of conventional synthetic methods with the delicate and complex functional groups present in these molecules. Here, we report a heterogeneous metallaphotocatalytic strategy that addresses this limitation through an energy-transfer mechanism.

What they did: By embedding nickel catalytic centers within a photoactive covalent organic framework, we create a system that directly excites transient thiosugar-nickel complexes, thereby bypassing the high activation barriers inherent to conventional redox pathways. This approach enables site-selective and stereocontrolled thioglycosylation under mild, operationally simple conditions, featuring a high turnover frequency (114 per hour) and exceptional catalyst recyclability. The broad scope of the method is demonstrated through the glycosylation of diverse substrates, including amino acids and bioactive peptides, without the need for protecting groups.

Results & conclusions: Notably, this method enables the first heterogeneous photocatalytic glycosylation of an antimicrobial peptide mastoparan, enhancing its antitumor activity. This work provides a versatile and sustainable tool for precision bioconjugation, offering immediate potential in drug discovery and chemical biology.

Abstract © the authors / Science Advances (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1126/sciadv.aed3764 · PubMed 42715335.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Science Advances for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Science Advances study find?

This work provides a versatile and sustainable tool for precision bioconjugation, offering immediate potential in drug discovery and chemical biology.

What type of study is this?

It is a research study, published in Science Advances in 2026. By embedding nickel catalytic centers within a photoactive covalent organic framework, we create a system that directly excites transient thiosugar-nickel complexes, thereby bypassing the high activation barriers inherent to conventional redox pathways.

Where can I read the original paper?

The original is at the publisher via DOI 10.1126/sciadv.aed3764. PubMed ID: 42715335. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Chen H, Yang X, Song Q et al.. Heterogeneous energy-transfer metallaphotocatalysis unlocks direct and site-selective thioglycosylation of unprotected thiosugars.. Science Advances (2026). DOI: 10.1126/sciadv.aed3764.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/heterogeneous-energy-transfer-metallaphotocatalysis-unlocks-direct-and-s-ed3764/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides